CMMB vs TFC · $22.2M cap vs rev $11.82B
Chemomab Therapeutics Ltd DRC (CMMB) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
TFC (TFC) common stock.
CMMB does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
CMMB currently screens at market cap $22.2M. TFC currently screens at market cap $0.
Not investment advice. Open the CMMB and TFC stock pages for the full models.
Not investment advice.